Abstract
Appropriate selection of patients with acute stroke for intravenous tissue plasminogen activator (t-PA) treatment is essential to maximize the probability of good outcome and to minimize treatment complications, particularly intracerebral hemorrhage. Guidelines specify withholding antiplatelet therapy for 24 hours after intravenous (IV) t-PA administration, but whether prior use of antiplatelet agents raises the risk for hemorrhage is uncertain. In this study, …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
